医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Olea Medical to Join Toshiba Medical Systems Corporation Group

2015年10月14日 AM12:54
このエントリーをはてなブックマークに追加


 

OTAWARA, Japan

Toshiba Medical Systems Corporation (“Toshiba”) announced today that Toshiba has completed the acquisition of the outstanding shares of Olea Medical SA (“Olea”), following approval from the French Ministry of Economy.

This acquisition enables Toshiba to accelerate the growth of its MRI business and offer new clinical added value to healthcare providers by leveraging Olea’s cutting-edge software technology for advanced post-processing and image analysis, as well as its broad relationships with the world’s key research institutions and customers.

“This partnership means we will benefit from both Toshiba’s and Olea’s strengths to accelerate innovation and enhance our global presence,” said Toshio Takiguchi, president and CEO of Toshiba Medical Systems Corporation. “Through the integration of both R&D teams, we believe we could bring the innovative solutions and products to play an important role in the development of MRI systems.”

Fayçal Djeridane, president and CEO of Olea Medical SA, stated, “This is great news for Olea’s customers and our fabulous team, and we are happy and proud to join the Toshiba family. We are convinced this is the right strategy to pursue our commitment to provide a widely accessible, complete package of simple, safe, fast and accurate tools for full-body image post-processing, in order to help doctors improve the diagnosis and follow-up process for patients’ benefit worldwide.”

Toshiba will also be able to provide multimodality solutions by integrating Olea’s post-processing software with Vitrea, a widely known enterprise and scanner-connected workstation by Vital Images Inc., another subsidiary of Toshiba, to improve collaboration among experts, consolidate and standardize workflows and enhance diagnostic confidence.

About Olea Medical

Olea Medical™ designs and markets innovative medical imaging applications that significantly improve diagnostic processes and treatment evaluation. Created in July 2008, Olea Medical has continuously increased its portfolio of innovative vendor-neutral software applications for MRI and CT imaging post-processing, including emergency settings—dedicated ones. Olea Medical’s competitive solutions allowing sped up and enhanced diagnosis process are now implemented in major healthcare centers all over the world, and Olea Medical aims to become the leading provider of safe and accurate medical imaging software. More information at www.olea-medical.com.

About Toshiba Medical Systems Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba. Visit Toshiba Medical Systems Corporation’s website at www.toshibamedicalsystems.com.

About Toshiba

Toshiba Corporation, a Fortune Global 500 company, channels world-class capabilities in advanced electronic and electrical product and systems into five strategic business domains: Energy & Infrastructure, Community Solutions, Healthcare Systems & Services, Electronic Devices & Components, and Lifestyles Products & Services. Guided by the principles of The Basic Commitment of the Toshiba Group, “Committed to People, Committed to the Future,” Toshiba promotes global operations and is contributing to the realization of a world where generations to come can live better lives.

Founded in Tokyo in 1875, today’s Toshiba is at the heart of a global network of over 580 consolidated companies employing 199,000 people worldwide, with annual sales surpassing 6.6 trillion yen (US$55 billion). To find out more about Toshiba, visit www.toshiba.co.jp/index.htm.

Olea Medical is a trademark of Olea Medical SA.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151013006421/en/

CONTACT

Toshiba Medical Systems Corporation
Rachel Miller, (714) 669-7623
rachel.miller@toshiba.com
or
Michael
Stewart, (310) 437-2523
michael.stewart@ketchum.com
or
Teruhiko
Kogane, +81-287-26-5100
teruhiko.kogane@toshiba.co.jp

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • BioVectra与Keryx Biopharmaceuticals签署枸橼酸铁扩产协议
  • Eternity Healthcare Inc. Enters into Share Exchange Agreement with Guizho Tongren Healthy China Biotechnology Co. Ltd.
  • Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease
  • Chi-Med Initiates Fruquintinib U.S. Clinical Trials
  • Orthocell Granted European Tendon Regeneration Patent